EDESA BIOTECH, INC.
Income Statement
| Line Item | FY2013 | FY2012 |
|---|---|---|
| Revenue | $545.5K | $286.1K |
| Cost of Revenue | $57.4K | $426.3K |
| Gross Profit | $488.1K | $-140.3K |
| Gross Margin | 89.5% | -49.0% |
| Operating Expenses | ||
| Research & Development | $2.0M | $2.6M |
| SG&A Expense | $1.8M | $3.7M |
| Operating Income | $-14.5M | $-5.5M |
| Operating Margin | -2,657.3% | -1,932.7% |
| Interest Expense | — | — |
| Pretax Income | $-14.5M | $-5.5M |
| Income Tax Expense | $800 | $800 |
| Net Income | $-14.5M | $-5.5M |
| Net Margin | -2,657.5% | -1,932.9% |
| EPS (Basic) | $-2.81 | $-0.13 |
| EPS (Diluted) | $-2.81 | $-0.13 |
| Shares Outstanding (Basic) | 5.2M | — |
| Shares Outstanding (Diluted) | 5.2M | — |
| Dividends Per Share | — | — |